Article

What We're Reading: Greater Campaign Dollars for Lawmakers Who Opposed Part B Demo

Author(s):

What We're Reading, July 11, 2016: US lawmakers who signed letters opposing the Medicare Part B demonstration received bigger monetary support from Big Pharma; e-cigarettes could push adolescents toward smoking cigarettes; and Hillary Clinton says she supports lowering Medicare enrollment age.

Lawmakers who were vocal in their opposition to CMS’ Medicare Part B demonstration proposal received significantly more financial support from the pharmaceutical industry than those who were not. Public Citizen reports that US representatives received 82% greater contributions (a total of $7,236,806 for 310 representatives) for their 2016 campaigns from the pharmaceutical and health products industry if they had signed either 1 of 2 letters that opposed the project. The 124 who did not, received a combined $1,585,857.

The FDA’s recent decision to regulate e-cigarettes could not have come at a more appropriate time. A new study released today in the journal Pediatrics has found that e-cigarette users had a 6-times greater likelihood of initiating cigarette use compared with those who did not use e-cigarettes. Further, the association was much stronger in the adolescent population interviewed for the study. The authors conclude that some of the e-cigarette users are teens who would not have smokes regular cigarettes if not exposed to vapes.

Two weeks before the Democratic National Convention, Hillary Clinton indicated that she supports a “public option” in health insurance. According to The Washington Post, the Clinton campaign released a statement that said she would support allowing people 55 and older to buy into Medicare. The statement also affirmed her support for increased funding for primary-care services at community-based centers in rural parts of the nation. Bernie Sanders is expected to endorse Clinton this week.

Related Videos
Jawad Haider Butt, MD, PhD
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Andrew Kuykendall, MD, Moffitt Cancer Center
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo